Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Friday's Intraday Session

Author: Benzinga Insights | December 01, 2023 01:31pm

Gainers

  • NexImmune (NASDAQ:NEXI) stock moved upwards by 540.4% to $11.07 during Friday's regular session. The market value of their outstanding shares is at $11.7 million.
  • Generation Bio (NASDAQ:GBIO) shares rose 31.81% to $1.49. The company's market cap stands at $98.4 million.
  • Altimmune (NASDAQ:ALT) shares rose 28.48% to $4.06. The market value of their outstanding shares is at $218.1 million.
  • Cyclerion Therapeutics (NASDAQ:CYCN) stock increased by 22.01% to $2.66. The company's market cap stands at $6.5 million.
  • Processa Pharma (NASDAQ:PCSA) shares rose 21.87% to $0.78. The company's market cap stands at $19.2 million.
  • Genelux (NASDAQ:GNLX) shares moved upwards by 21.0% to $14.4. The market value of their outstanding shares is at $384.7 million.

Losers

  • Ampio Pharmaceuticals (AMEX:AMPE) shares fell 42.7% to $3.3 during Friday's regular session. The company's market cap stands at $2.7 million.
  • Intelligent Bio Solutions (NASDAQ:INBS) shares declined by 28.46% to $0.3. The company's market cap stands at $2.6 million.
  • LumiraDx (NASDAQ:LMDX) stock declined by 23.54% to $0.13. The market value of their outstanding shares is at $42.0 million.
  • Soligenix (NASDAQ:SNGX) stock declined by 20.41% to $0.78. The market value of their outstanding shares is at $8.0 million.
  • Cartesian Therapeutics (NASDAQ:RNAC) shares declined by 20.0% to $1.08. The market value of their outstanding shares is at $174.8 million.
  • Ensysce Biosciences (NASDAQ:ENSC) shares decreased by 19.79% to $0.91. The company's market cap stands at $2.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ALT AMPE CYCN ENSC GBIO GNLX INBS LMDX NEXI PCSA RNAC SNGX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist